Hypermarcas (OTCMKTS:HYPMY) Shares Gap Down – Should You Sell?

Hypermarcas (OTCMKTS:HYPMY) gapped down prior to trading on Wednesday . The stock had previously closed at $4.16, but opened at $3.96. Hypermarcas shares last traded at $4.0185, with a volume of 541 shares traded.

Wall Street Analyst Weigh In

Several brokerages have commented on HYPMY. Jefferies Financial Group upgraded Hypermarcas to a “strong-buy” rating in a research note on Monday. Zacks Research upgraded Hypermarcas to a “hold” rating in a research note on Wednesday, April 29th. One analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, Hypermarcas currently has a consensus rating of “Buy”.

Hypermarcas Stock Down 0.1%

The company has a market cap of $2.81 billion, a PE ratio of 8.31 and a beta of 0.71. The company’s fifty day moving average is $4.16 and its 200-day moving average is $4.38.

Hypermarcas (OTCMKTS:HYPMY) last released its quarterly earnings results on Wednesday, April 29th. The company reported $0.10 earnings per share for the quarter. The firm had revenue of $383.13 million for the quarter. Hypermarcas had a return on equity of 14.08% and a net margin of 19.41%. Equities research analysts expect that Hypermarcas will post 0.53 EPS for the current fiscal year.

About Hypermarcas

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.